Lloyd Mitchell Segal's Net Worth
$844 Thousand
Who is Lloyd Mitchell Segal?
Lloyd Mitchell Segal does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOVAIL Corp, and Repare Therapeutics Inc..
SEC CIK
Lloyd Mitchell Segal's CIK is 0001477123
Past Insider Trading and Trends
2010 was Lloyd Mitchell Segal's most active year for acquiring shares with 6 total transactions. Lloyd Mitchell Segal's most active month to acquire stocks was the month of May. 2013 was Lloyd Mitchell Segal's most active year for disposing of shares, totalling 2 transactions. Lloyd Mitchell Segal's most active month to dispose stocks was the month of April. 2013 saw Lloyd Mitchell Segal paying a total of $246,732.00 for 7,962 shares, this is the most they've acquired in one year. In 2013 Lloyd Mitchell Segal cashed out on 40,667 shares for a total of $3,692,970.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.67% | 140 |
$85.45 | $11,963.00 | 21.17K |
Jun 14
| |||
Form 4
| +17.27% | 3.19K |
$85.15 | $268,486.20 | 21.66K |
Jun 11 - Jun 12
| |||
Form 4
| -19.23% | -4.40K |
$90.81 | -$399,291.57 | 18.47K |
May 30
| |||
Form 4
| +28.14% | 5.02K |
—
|
—
| 22.87K |
May 24
| |||
Form 4
| +1.36% | 240 |
$54.28 | $13,027.20 | 17.85K |
Nov 9
| |||
Form 4
| +1.36% | 240 |
$54.28 | $13,027.20 | 17.85K |
Nov 9
| |||
Form 4
| +4.42% | 745 |
$54.44 | $40,555.56 | 17.61K |
Nov 6
| |||
Form 4
| +3.04% | 498 |
—
|
—
| 16.86K |
Jun 30
| |||
Form 4
| +97.09% | 8.06K |
—
|
—
| 16.37K |
Jun 4
| |||
Form 4
| +5.15% | 407 |
—
|
—
| 8.3K |
Mar 31
| |||
Form 4
| +125.63% | 4.4K |
—
|
—
| 7.9K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.56% | -5.14K |
$4.62 | -$23,776.33 | 107.56K |
Scheduled
|
Mar 28 - Apr 1
| ||
Form 4
| -8.66% | -7.95K |
$4.69 | -$37,259.00 | 83.87K |
Scheduled
|
Mar 25 - Mar 27
| ||
Form 4
| +47.24% | 40K |
—
|
—
| 124.68K |
Mar 1
| |||
Form 4
| +1,282.03% | 78.55K |
—
|
—
| 84.68K |
Jan 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| -1.61% | -1.54K |
$35.61 | -$54,910.62 | 94.47K |
Scheduled
|
Jun 28
| ||
Form 4
| -1.62% | -1.58K |
$35.00 | -$55,160.00 | 96.01K |
Scheduled
|
Jun 9
| ||
Form 4
| -25.98% | -36.00K |
$16.41 | -$1,267,181.64 | 102.58K |
Jun 3 - Jun 4
| |||
Form 4
| -2.74% | -3.77K |
$35.03 | -$132,065.36 | 133.58K |
Scheduled
|
May 20
| ||
Form 4
| -3.92% | -5.60K |
$35.04 | -$196,228.00 | 137.35K |
Scheduled
|
May 18 - May 19
| ||
Form 4
| -3.71% | -5.51K |
$35.01 | -$192,975.12 | 142.95K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 5K |
$20.00 | $100,000.00 | 5K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||